Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients

American Journal of Epidemiology

Volumn 146, Issue 8, 1997, Pages 655-661

  Operskalski, Eva A ^a   Stram, Daniel O ^a   Busch, Michael P ^b,c   Huang, Wei ^a   Harris, Marcia ^a   Dietrich, Shelby L ^d   Schiff, Eugene R ^e   Donegan, Elizabeth ^c   Mosley, James W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Blood Centers of the Pacific   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HUNTINGTON MEMORIAL HOSPITAL   (United States)

^e UNIVERSITY OF MIAMI   (United States)

Author keywords

Blood transfusion; HIV; Sexually transmitted diseases; Viremia

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; RISK FACTOR; VIREMIA; VIRUS TRANSMISSION;

EID: 0030700569     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009331     Document Type: Article

References (56)

1. Kreiss JK, Kitchen LW, Prince HE, et al. Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Ann Intern Med 1985;102:623-6.
2. Biberfeld G, Bottiger B, Berntorp E, et al. Transmission of HIV infection to heterosexual partners but not to household contacts of seropositive haemophiliacs. Scand J Infect Dis 1986;18:497-500.
3. Jason JM, McDougal JS, Dixon G, et al. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. JAMA 1986;255:212-15.
4. Allain JP. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France. N Engl J Med 1986;315:517-18.
5. Peterman TA, Stoneburner RL, Allen JR, et al. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 1988;259:55-8.
6. Padian NS, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA 1991;266:1664-7.
7. Seidlin M, Vogler M, Lee E, et al. Heterosexual transmission of HIV in a cohort of couples in New York City. AIDS 1993;7:1247-54.
8. Ghirardini A, Chiarotti F, Schinaia N, et al. Testing practices and spread of HIV among sexual partners of HIV-positive haemophiliacs in Italy. AIDS 1993;7:573-7.
9. Fischl MA, Dickinson GM, Scott GB, et al. Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA 1987;257:640-4.
10. Goedert JJ, Eyster ME, Biggar RJ, et al. Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res Hum Retroviruses 1987;3:355-61.
11. Brettler DB, Forsberg AD, Levine PH, et al. Human immunodeficiency virus isolation studies and antibody testing. Arch Intern Med 1988;148:1299-301.
12. Smiley ML, White GC, Becherer P, et al. Transmission of human immunodeficiency virus to sexual partners of hemophiliacs. Am J Hematol 1988;28:27-32.
13. Ragni MV, Kingsley LA, Nimorwicz P, et al. HIV heterosexual transmission in hemophilia couples: lack of relation to T4 number, clinical diagnosis, or duration of HIV exposure. J Acquir Immune Defic Syndr 1989;2:557-63.
14. Johnson AM, Petherick A, Davidson SJ, et al. Transmission of HIV to heterosexual partners of infected men and women. AIDS 1989;3:367-72.
15. Lusher JM, Operskalski EA, Aledort LM, et al. Risk of human immunodeficiency virus type 1 infection among sexual and non-sexual household contacts of persons with congenital clotting disorders. Pediatrics 1991;88:242-9.
16. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992;304:809-13.
17. O'Brien TR, Busch MP, Donegan E, et al. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr 1994;7:705-10.
18. MacGregor RR, Dublin G, Frank I, et al. Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals. Clin Infect Dis 1995;21:122-7.
19. Eyster ME, Goedert JJ. Apparent heterosexual transmission of HIV infection from an asymptomatic haemophiliac to his wife three or more years after seroconversion. AIDS 1987;1:131-4.
20. De Vicenzi I, European Study Group on Heterosexual Transmission of HIV. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994;331:341-6.
21. Siddiqui NS, Brown LS, Phillips RY, et al. No seroconversions among steady sex partners of methadone-maintained HIV-1 seropositive injecting drug users in New York City. AIDS 1992;6:1529-33.
22. Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr 1993;6:497-502.
23. Padian NS, O'Brien TR, Chang Y, et al. Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr 1993;6:1043-8.
24. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
25. Coombs RW, Collier AC, Allain J-P, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321:1626-31.
26. Genesca J, Wang RY-H, Alter HJ, et al. Clinical correlation and genetic polymorphism of the human immunodeficiency virus proviral DNA obtained after polymerase chain reaction amplification. J Infect Dis 1990;162:1025-30.
27. Schnittman SM, Greenhouse JJ, Psallidopoulos MC, et al. Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990;113:438-43.
28. Saag MS, Crain MJ, Decker WD, et al. High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis 1991;164:72-80.
29. Aoki-Sei S, Yarchoan R, Kageyama S, et al. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res Hum Retroviruses 1992;8:1263-70.
30. Connor RI, Mohri H, Cao Y, et al. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67:1772-7.
31. Piatak M, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-54.
32. Lee T-H, Sheppard HW, Reis M, et al. Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr 1994;7:381-8.
33. Jurriaans S, Van Gemen B, Weverling GJ, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994;204:223-33.
34. Verhofstede C, Reniers S, Van Wanzeele F, et al. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease. AIDS 1994;8:1421-7.
35. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
36. Henrard DR, Phillips JF, Muenz LR, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995;274:554-8.
37. Henrard DR, Daar E, Farzadegan H, et al. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr 1995;9:305-10.
38. Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113:733-9.
39. Edwards VM, Mosley JM, Transfusion Safety Study Group. Reproducibility in quality control of protein (Western) immunoblot assay for antibodies to human immunodeficiency virus. Am J Clin Pathol 1989;91:75-8.
40. Mulder J, McKinney N, Christopherson C, et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
41. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1994;170:553-62.
42. Fletcher MA, Azen SP, Adelsberg B, et al. Immunophenotyping in a multicenter study: the Transfusion Safety Study experience. Clin Immunol Immunopathol 1989;52:38-47.
43. Parker JW, Adelsberg B, Azen SP, et al. Leukocyte immunophenotyping by flow cytometry in a multisite study: standardization, quality control, and normal values in the Transfusion Safety Study. Clin Immunol Immunopathol 1989;55:187-220.
44. Esteban JI, Shih JW, Tai CC, et al. Importance of Western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet 1985;2:1083-6.
45. Groopman JE, Caiazzo T, Thomas MA, et al. Lack of evidence of prolonged human immunodeficiency virus infection before antibody seroconversion. Blood 1988;71:1752-4.
46. Horsburgh CR, Ou C-Y, Jason J, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989;2:637-40.
47. Ho DD, Sarngadharan MG, Resnick L, et al. Primary human T-cell lymphotropic virus type III infection. Ann Intern Med 1985;103:880-3.
48. Remis RS, O'Shaughnessy MV, Tsoukas C, et al. HIV transmission to patients with hemophilia by heat-treated, donor-screened factor concentrate. Can Med Assoc J 1990;142:1247-54.
49. Needlestick transmission of HTLV-III from a patient infected in Africa. (Editorial). Lancet 1984;2:1376-7.
50. Cooper DA, Gold J, MacLean P, et al. Acute AIDS retrovirus infection: definition of a clinical illness associated with seroconversion. Lancet 1985;1:537-40.
51. Gaines H, von Sydow M, Sonnerborg A, et al. Antibody response in primary human immunodeficiency virus infection. Lancet 1987;1:1249-53.
52. Loveday C, Hill A. Prediction of progression to AIDS with serum HIV-1 RNA and CD4 count. Lancet 1995;345:790-1.
53. Gupta P, Kingsley L, Armstrong J, et al. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 1993;196:586-95.
54. Busch MP, Operskalski EA, Mosley JW, et al. Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion, J Infect Dis 1996;174:26-33.
55. De Vincenzi I. Heterosexual transmission of HIV. (Letter). JAMA 1992;267:1919.
56. Phillips A, Johnson A. Female-to-male transmission of HIV. (Letter). JAMA 1992;268:1855-6.